Skip to main content
Top
Published in: Archives of Osteoporosis 1/2020

01-12-2020 | Joint Pain | Case Report

Osteogenesis imperfecta and rheumatoid arthritis: is there a link?

Authors: Laura Otilia Damian, Carmen-Delia Zmarandache, Paulina Vele, Adriana Albu, Cristina Belizna, Alexandra Crăciun

Published in: Archives of Osteoporosis | Issue 1/2020

Login to get access

Abstract

Summary

We present the cases of a mother and daughter with osteogenesis imperfecta, also diagnosed later with rheumatoid arthritis. In our patients finding and treating the over-imposed arthritis improved the joint pain initially attributed to osteogenesis imperfecta. Exploring joint inflammation in this setting could help ease the disease burden.

Purpose

Osteogenesis imperfecta (OI) is a rare hereditary disease evolving with recurrent fractures upon minor trauma, blue sclerae, and hearing loss. Although inflammation was not generally considered a feature of the disease, systemic inflammation was recently reported in children with OI and in murine models of OI.

Method

We present the cases of a mother and a daughter with OI, without a personal or family history of autoimmune diseases, who were also diagnosed with rheumatoid arthritis seropositive for anti-cyclic citrullinated peptide autoantibodies and rheumatoid factor.

Results

The genetic tests identified in both patients a deletion in COL1A1 gene (c.3399del, p.Ala1134Profs*105), not previously reported, not present in population databases, creating a premature translational stop signal in the COL1A1 gene in the collagen I major ligand binding region 3. In our patients finding and treating the over-imposed arthritis improved the joint pain initially attributed to OI. Possible pathogenic links between OI and RA are discussed.

Conclusion

The prevalence of joint inflammation in OI is unknown and may be underestimated. As musculoskeletal involvement affects the quality of life in most OI patients, exploring this relation may help ease the disease burden.
Appendix
Available only for authorised users
Literature
2.
go back to reference Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, Hyland JC, Körkkö J, Prockop DJ, De Paepa A, Coucke P, Symoens S, Glorieux FH, Roughley PJ, Lund AM, Kuurila-Svahn K, Hartikka H, Cohn DH, Krakow D, Mottes M, Schwarze U, Chen D, Yang K, Kuslich C, Troendle J, Dalgleish R, Byers PH (2007) Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 28:209–221. https://doi.org/10.1002/humu.20429CrossRefPubMedPubMedCentral Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, Hyland JC, Körkkö J, Prockop DJ, De Paepa A, Coucke P, Symoens S, Glorieux FH, Roughley PJ, Lund AM, Kuurila-Svahn K, Hartikka H, Cohn DH, Krakow D, Mottes M, Schwarze U, Chen D, Yang K, Kuslich C, Troendle J, Dalgleish R, Byers PH (2007) Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 28:209–221. https://​doi.​org/​10.​1002/​humu.​20429CrossRefPubMedPubMedCentral
4.
10.
go back to reference Brunetti G, Papadia F, Tummolo A, Fischetto R, Nicastro F, Piacente Ventura A, Mori G, Oranger A, Gigante I, Colucci S, Ciccarelli M, Grain M, Cavallo L, Delvecchio M, Faienza MF (2016) Impaired bone remodelling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-alpha. Osteopor Int 27(7):2355–2365. https://doi.org/10.1007/s00198-016-3501-2CrossRef Brunetti G, Papadia F, Tummolo A, Fischetto R, Nicastro F, Piacente Ventura A, Mori G, Oranger A, Gigante I, Colucci S, Ciccarelli M, Grain M, Cavallo L, Delvecchio M, Faienza MF (2016) Impaired bone remodelling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-alpha. Osteopor Int 27(7):2355–2365. https://​doi.​org/​10.​1007/​s00198-016-3501-2CrossRef
13.
go back to reference Thiele F, Cohrs CM, Flor A, Lisse TS, Przemeck GK, Horsch M, Schrewe A, Gailus-Durner V, Ivandic B, Katus HA, Wurst W, Reisenberg C, Chaney H, Fuch H, Hans W, Beckers J, Marini JC, Hrabe de Angelis M (2012) Cardiopulmonary dysfunction in osteogenesis imperfecta. Hum Molec Genet 21(16):3535–3545. https://doi.org/10.1093/hmg/dds183CrossRefPubMed Thiele F, Cohrs CM, Flor A, Lisse TS, Przemeck GK, Horsch M, Schrewe A, Gailus-Durner V, Ivandic B, Katus HA, Wurst W, Reisenberg C, Chaney H, Fuch H, Hans W, Beckers J, Marini JC, Hrabe de Angelis M (2012) Cardiopulmonary dysfunction in osteogenesis imperfecta. Hum Molec Genet 21(16):3535–3545. https://​doi.​org/​10.​1093/​hmg/​dds183CrossRefPubMed
20.
go back to reference Mazzantini M, Di Munno O (2000) Methotrexate and bone mass. Clin Exp Rheumatol 18(Suppl21):S87–S92 Mazzantini M, Di Munno O (2000) Methotrexate and bone mass. Clin Exp Rheumatol 18(Suppl21):S87–S92
Metadata
Title
Osteogenesis imperfecta and rheumatoid arthritis: is there a link?
Authors
Laura Otilia Damian
Carmen-Delia Zmarandache
Paulina Vele
Adriana Albu
Cristina Belizna
Alexandra Crăciun
Publication date
01-12-2020
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2020
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-020-0681-3

Other articles of this Issue 1/2020

Archives of Osteoporosis 1/2020 Go to the issue